Search - tctmd.com

Displaying 1 - 20 of 134

Sort: Relevancy | Date

News Daily News

Rise in CV Risk Factors Tied to Vulnerable Plaque in ACS Patients

Caitlin E. Cox

July 14, 2025

News Conference News ACC 2025

Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI

Caitlin E. Cox

March 30, 2025

Presentation TCT 2024

CV Event Reduction is the Essential Criterion for Implementing New Device Therapies

Presenter: Ori Ben-Yehuda

October 30, 2024

News Conference News TCT 2022

Late Catch-up Sours SUGAR for Polymer-Free Stent in Diabetic Patients

Yael L. Maxwell

September 27, 2022

News Conference News TCT 2022

CCTA in Patients With Prior CABG Cuts Complications of Invasive Angio: BYPASS-CTCA

Yael L. Maxwell

September 21, 2022

News Conference News TCT 2022

SCAAR Registry Delves Into Left Main Revascularization Outcomes

Michael O'Riordan

September 19, 2022

Presentation TVT 2022

Heterotopic Tricuspid Valve Replacement: Considerations for Future Clinical Trials

Presenter: Ori Ben-Yehuda

June 08, 2022

Presentation THT 2022

Innovation in Heart Failure Trial Designs

Presenter: Ori Ben-Yehuda

February 02, 2022

Presentation TCT 2021

Perspectives on TEER Trials in Secondary MR (Control Groups, Enrollment Issues, and More)

Presenter: Ori Ben-Yehuda

November 05, 2021

News Features

Expired Cardiac Devices May Do Global Good, but Safety Unknown

Yael L. Maxwell

August 26, 2021

Presentation TVT 2021

The Future Role of TAVR in AR Therapy: Mapping an Evidence-Based Pathway

Presenter: Ori Ben-Yehuda

July 21, 2021

Podcast Heart Sounds

Shelley Wood Talks COVID-19 Vaccines With Francesca Torriani and Ori Ben-Yehuda

March 31, 2021

News Conference News TCT 2020

OPTIMIZE: Svelte Direct Stenting Device Fails to Match DES

L.A. McKeown

October 17, 2020

Presentation TCT 2019

The Angiogram: Charting the Course for Effective Lipid Management

Presenter: Ori Ben-Yehuda

September 28, 2019

Presentation TCT 2019

Introduction to Pulmonary Artery Denervation: Rationale

Presenter: Ori Ben-Yehuda

September 27, 2019

Presentation TCT 2019

Classification of Pulmonary Hypertension and Overview of CTEPH

Presenter: Ori Ben-Yehuda

September 27, 2019

Presentation TCT 2019

Excel: Extended Follow-Up and Most Important Substudies

Presenter: Ori Ben-Yehuda

September 27, 2019

News Conference News TCT 2019

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Caitlin E. Cox

September 26, 2019

Presentation TCT 2019

FDA Pivotal Clinical Trial Design and Beyond

Presenter: Ori Ben-Yehuda

September 26, 2019

News Conference News TCT 2019

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

Yael L. Maxwell

September 26, 2019

Advertisement

Rise in CV Risk Factors Tied to Vulnerable Plaque in ACS Patients

Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI

CV Event Reduction is the Essential Criterion for Implementing New Device Therapies

Late Catch-up Sours SUGAR for Polymer-Free Stent in Diabetic Patients

CCTA in Patients With Prior CABG Cuts Complications of Invasive Angio: BYPASS-CTCA

SCAAR Registry Delves Into Left Main Revascularization Outcomes

Heterotopic Tricuspid Valve Replacement: Considerations for Future Clinical Trials

Innovation in Heart Failure Trial Designs

Perspectives on TEER Trials in Secondary MR (Control Groups, Enrollment Issues, and More)

Expired Cardiac Devices May Do Global Good, but Safety Unknown

The Future Role of TAVR in AR Therapy: Mapping an Evidence-Based Pathway

Shelley Wood Talks COVID-19 Vaccines With Francesca Torriani and Ori Ben-Yehuda

OPTIMIZE: Svelte Direct Stenting Device Fails to Match DES

The Angiogram: Charting the Course for Effective Lipid Management

Introduction to Pulmonary Artery Denervation: Rationale

Classification of Pulmonary Hypertension and Overview of CTEPH

Excel: Extended Follow-Up and Most Important Substudies

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

FDA Pivotal Clinical Trial Design and Beyond

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content